The CRISPR screen also highlighted that invasive GBM cells were dependent on this increased transsulfuration such that the rate-limiting CTH step represented a therapeutic vulnerability as the only step whose targeting slowed invasion. The gene discussed is CTH; the disease is glioblastoma.